Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114(21):E4184-E4192.

Geyer JT, Mathew S. Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification. Int J Hematol. 2017;106(4):457-458.

Scognamiglio T. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid. Arch Pathol Lab Med. 2017;141(12):1646-1652.

Wang P, Byrum S, Fowler FC, Pal S, Tackett AJ, Tyler JK. Proteomic identification of histone post-translational modifications and proteins enriched at a DNA double-strand break. Nucleic Acids Res. 2017;45(19):10923-10940.

Nwanze J, Siddiqui MT, Stevens KA, Saxe D, Cohen C. MYC Immunohistochemistry Predicts Rearrangements by FISH. Front Oncol. 2017;7:209.

Caliò A, Bria E, Pilotto S, Gilioli E, Nottegar A, Eccher A, et al. ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes. Cancer Biomark. 2017;18(2):215-220.

Wilkes DC, Sailer V, Xue H, Cheng H, Collins CC, Gleave M, et al. A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents. Cold Spring Harb Mol Case Stud. 2017;3(5).

Codispoti B, Rinaldo N, Chiarella E, Lupia M, Spoleti CB, Marafioti MG, et al. Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells. Oncotarget. 2017;8(27):43782-43798.

Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, et al. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer. Virchows Arch. 2017;470(6):711-715.

Jang K, Kim M, Gilbert CA, Simpkins F, Ince TA, Slingerland JM. VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells. EMBO Mol Med. 2017;9(3):304-318.